94 related articles for article (PubMed ID: 16902293)
1. Tempting liver fibrosis? Long-term psoriatic methotrexate therapy and heterozygous alpha1-antitrypsin deficiency.
Mathew J; Igbokwe UO; Morley N; Burt AD
Dermatology; 2006; 213(2):147-9. PubMed ID: 16902293
[TBL] [Abstract][Full Text] [Related]
2. A liver fibrosis cocktail? Psoriasis, methotrexate and genetic hemochromatosis.
Mathew J; Leong MY; Morley N; Burt AD
BMC Dermatol; 2005 Nov; 5():12. PubMed ID: 16316460
[TBL] [Abstract][Full Text] [Related]
3. Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy.
Lindsay K; Fraser AD; Layton A; Goodfield M; Gruss H; Gough A
Rheumatology (Oxford); 2009 May; 48(5):569-72. PubMed ID: 19273538
[TBL] [Abstract][Full Text] [Related]
4. Alpha-1-antitrypsin deficiency in children: liver disease is not reflected by low serum levels of alpha-1-antitrypsin - a study on 48 pediatric patients.
Lang T; Mühlbauer M; Strobelt M; Weidinger S; Hadorn HB
Eur J Med Res; 2005 Dec; 10(12):509-14. PubMed ID: 16356865
[TBL] [Abstract][Full Text] [Related]
5. The role of liver biopsies in psoriatic patients receiving long-term methotrexate treatment. Improvement in liver abnormalities after cessation of treatment.
Newman M; Auerbach R; Feiner H; Holzman RS; Shupack J; Migdal P; Culubret M; Camuto P; Tobias H
Arch Dermatol; 1989 Sep; 125(9):1218-24. PubMed ID: 2774597
[TBL] [Abstract][Full Text] [Related]
6. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.
Maurice PD; Maddox AJ; Green CA; Tatnall F; Schofield JK; Stott DJ
Br J Dermatol; 2005 Mar; 152(3):451-8. PubMed ID: 15787813
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate and liver function: a study of 13 psoriasis cases treated with different cumulative dosages.
Carneiro SC; Cássia FF; Lamy F; Chagas VL; Ramos-e-Silva M
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):25-9. PubMed ID: 18181969
[TBL] [Abstract][Full Text] [Related]
8. End-stage liver disease developing with the use of methotrexate in heterozygous alpha 1-antitrypsin deficiency.
Hilsden RJ; Urbanski SJ; Swain MG
Arthritis Rheum; 1995 Jul; 38(7):1014-8. PubMed ID: 7612033
[TBL] [Abstract][Full Text] [Related]
9. [Heterozygosity for alpha1-antitrypsin deficiency as a cofactor in the development of chronic liver disease].
Kok KF; Wahab PJ; de Vries RA
Ned Tijdschr Geneeskd; 2005 Sep; 149(37):2057-61. PubMed ID: 16184948
[TBL] [Abstract][Full Text] [Related]
10. Adalimumab therapy of psoriasis and psoriatic arthritis in a patient with cirrhosis of the liver.
Piel S; Dissemond J
J Am Acad Dermatol; 2008 Nov; 59(5 Suppl):S117-8. PubMed ID: 19119119
[No Abstract] [Full Text] [Related]
11. A patient with autoimmune hepatitis type I, Addison's disease, atrophic thyroiditis, atrophic gastritis, exocrine pancreatic insufficiency, and heterozygous alpha1-antitrypsin deficiency.
Bergwitz C; Brabant G; Trautwein C; Manns MP
Am J Gastroenterol; 2002 Apr; 97(4):1050-2. PubMed ID: 12003388
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate-induced cirrhosis requiring liver transplantation in three patients with psoriasis. A word of caution in light of the expanding use of this 'steroid-sparing' agent.
Gilbert SC; Klintmalm G; Menter A; Silverman A
Arch Intern Med; 1990 Apr; 150(4):889-91. PubMed ID: 2327848
[TBL] [Abstract][Full Text] [Related]
13. Liver biopsies from psoriatics related to methotrexate therapy. 2. Findings before and after methotexate therapy in 88 patients. A blind study.
Nyfors A; Poulsen H
Acta Pathol Microbiol Scand A; 1976 May; 84(3):262-70. PubMed ID: 1274591
[TBL] [Abstract][Full Text] [Related]
14. Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment.
Rosenberg P; Urwitz H; Johannesson A; Ros AM; Lindholm J; Kinnman N; Hultcrantz R
J Hepatol; 2007 Jun; 46(6):1111-8. PubMed ID: 17399848
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate hepatotoxicity and concentrations of methotrexate and folate in erythrocytes--relation to liver fibrosis and cirrhosis.
Zachariae H; Schrøder H; Foged E; Søgaard H
Acta Derm Venereol; 1987; 67(4):336-40. PubMed ID: 2445154
[TBL] [Abstract][Full Text] [Related]
16. Galactose tolerance test and methotrexate-induced liver fibrosis and cirrhosis in patients with psoriasis.
Lenler-Petersen P; Søgård H; Thestrup-Pedersen K; Zachariae H
Acta Derm Venereol; 1982; 62(5):448-9. PubMed ID: 6183903
[TBL] [Abstract][Full Text] [Related]
17. Comment on: Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy.
Boffa MJ; Smith A; Chalmers RJ
Rheumatology (Oxford); 2009 Nov; 48(11):1464; author reply 1465. PubMed ID: 19671697
[No Abstract] [Full Text] [Related]
18. Methotrexate for psoriasis: current European practice. A postal survey.
Boffa MJ
J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):196-202. PubMed ID: 15752290
[TBL] [Abstract][Full Text] [Related]
19. Does the heterozygous state of alpha-1 antitrypsin deficiency have a role in chronic liver diseases? Interim results of a large case-control study.
Regev A; Guaqueta C; Molina EG; Conrad A; Mishra V; Brantly ML; Torres M; De Medina M; Tzakis AG; Schiff ER
J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S30-5. PubMed ID: 16819398
[TBL] [Abstract][Full Text] [Related]
20. Liver biopsy in methotrexate-treated psoriatics-a re-evalution.
Zachariae H; Grunnet E; Sogaard H
Acta Derm Venereol; 1975; 55(4):291-6. PubMed ID: 52258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
